相关实验视频
Updated: Jul 17, 2025
09:11
Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
6.6K
慢结合抑制剂的演变 向希斯脱乙酶异型的缓慢结合抑制剂的演变
Anirban Mukherjee1, Farzad Zamani1, Takayoshi Suzuki1
1SANKEN, Osaka University, Mihogaoka, Ibaraki, Osaka 567-0047, Japan.
Journal of medicinal chemistry
|August 31, 2023
概括
与传统的HDAC抑制剂相比,缓慢结合的基因素脱乙酶 (HDAC) 抑制剂提供了更好的选择性和降低了毒性. 它们的发展对于治疗癌症和神经退行性疾病等疾病至关重要.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 激素脱乙酶 (HDAC) 的过度表达与各种疾病有关,包括癌症和神经退行性疾病.
- 目前的HDAC抑制剂往往缺乏子类和异型选择性,导致潜在的毒性问题.
- 希斯脱乙酶抑制剂被认为是有前途的治疗药物.
研究的目的:
- 探索慢结合的HDAC抑制剂的潜力和进展.
- 要突出慢结合的HDAC抑制剂相对于经典的酸盐抑制剂的优势.
- 强调开发用于治疗应用的选择性HDAC抑制剂的重要性.
主要方法:
- 这一观点审查了关于HDAC抑制剂的现有文献,重点关注慢结合抑制剂的作用机制.
- 经典和慢结合的HDAC抑制剂之间的选择性和毒性概况的比较分析.
- 讨论开发针对多种异构体的新型慢结合HDAC抑制剂的策略.
主要成果:
- 缓慢结合的HDAC抑制剂与HDAC酶形成紧密,长时间的结合,增强选择性.
- 这种独特的机制通过减少非目标效应和毒性来改善治疗指数.
- 与非选择性抑制剂相比,慢结合抑制剂对更广泛的疾病具有前景.
结论:
- 缓慢结合的HDAC抑制剂是有前途的治疗策略,因为它们提高了选择性和安全性.
- 进一步开发这些抑制剂对于有效治疗各种癌症和神经退行性疾病至关重要.
- 用慢结合抑制剂向广泛的HDAC异型,可能会导致更有效的疾病管理.
相关概念视频
02:32Histone Modification
13.4K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.4K
02:25Spreading of Chromatin Modifications
8.3K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.3K
01:30Enzyme Inhibition
78.7K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.7K
01:52Eukaryotic Transcription Inhibitors
9.9K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.9K
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.9K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.9K
02:30Histone Variants at the Centromere
4.4K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.4K